Wordt geladen...
HIV-1 vaccine immunogen design strategies
An effective human immunodeficiency virus type 1 (HIV-1) vaccine is expected to have the greatest impact on HIV-1 spread and remains a global scientific priority. Only one candidate vaccine has significantly reduced HIV-1 acquisition, yet at a limited efficacy of 31%, and none have delayed disease p...
Bewaard in:
| Gepubliceerd in: | Virol J |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318220/ https://ncbi.nlm.nih.gov/pubmed/25616599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-014-0221-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|